Skip to main content

Tak Mak moves to breast cancer

New $125m Toronto facility could be 'Manhattan Project of cancer,' says Mak

Written byDoug Payne
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Leading Canadian researcher Tak Mak announced last week (June 2) that he will head a new breast cancer research center in Toronto. The Institute for Breast Cancer Research (IBCR), based at the Princess Margaret Hospital, will focus on three areas: identifying genes to target for future cancer therapies—including the use of transgenics and knockout mice, Drosophila screening tumor and tissue banks/human samples, signal transduction, and cancer immunotherapy; developing new surgical, radiation, and drug treatments; and expanding the number of clinical trials—40 are now underway—conducted at the hospital.

The announcement garnered widespread support from international colleagues.

"The institute," wrote Jean-François Bach, the past president of the Necker Hospital in Paris, "represents a unique opportunity." Hans Wigzell, the former chair of the Nobel Prize Committee in Stockholm, said the facility, would likely be "a significant contributor in the global arena in the fight against this disease."

The IBCR hopes to raise CDN ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays